Micoy Therapeutics Receives FDA Breakthrough Designation for NeuroLume™ Test to Detect Folate Receptor Autoantibodies

FDA Breakthrough designation supports development of a point-of-care test for detecting folate receptor autoantibodies ...

Can the prescription drug leucovorin treat autism? History says, probably not

Parents of autistic children are clamoring for a prescription vitamin promoted by federal health officials. But there's ...
The American Journal of Managed Care

Low Clinical Utility of Folate Determinations in Primary Care Setting

It seems that folate determinations in patients without known risk factors for folate deficiency are of little clinical significance. Fortification of cereal products with folic acid is not mandatory ...
Knoxville News Sentinel

Micoy Therapeutics Receives FDA Breakthrough Designation for NeuroLume™ Test to Detect Folate Receptor Autoantibodies

NEW YORK, NY, UNITED STATES, January 12, 2026 /EINPresswire.com/ — Micoy Therapeutics today announced that the NeuroLume™ Test has been granted Breakthrough ...